Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments
暂无分享,去创建一个
Zheng Guo | Qingzhou Guan | Lu Ao | Haidan Yan | Hongwei Wang | Mengyao Li | Hao Cai | Zheng Guo | Hongwei Wang | Qingzhou Guan | M. Tong | L. Ao | Haidan Yan | H. Cai | Xiangyu Li | Mengyao Li | Tingting Zheng | Xiangyu Li | Mengsha Tong | T. Zheng | Mengsha Tong | Lu Ao | Tingting Zheng
[1] J. Valcárcel,et al. The spliceosome as a target of novel antitumour drugs , 2012, Nature Reviews Drug Discovery.
[2] Robert Brown,et al. Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling , 2012, Oncogene.
[3] X. Lin,et al. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin. , 2001, Cancer research.
[4] John Quackenbush. Microarray data normalization and transformation , 2002, Nature Genetics.
[5] G. Giaccone,et al. Cathepsin B Mediates Caspase-Independent Cell Death Induced by Microtubule Stabilizing Agents in Non-Small Cell Lung Cancer Cells , 2004, Cancer Research.
[6] Jing Zhu,et al. GO-function: deriving biologically relevant functions from statistically significant functions , 2012, Briefings Bioinform..
[7] J. Foekens,et al. LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy. , 2014, Endocrine-related cancer.
[8] A. Motegi,et al. The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy. , 2009, Cancer letters.
[9] M. Jäättelä,et al. Combating apoptosis and multidrug resistant cancers by targeting lysosomes. , 2013, Cancer letters.
[10] M. Wyatt,et al. Participation of DNA repair in the response to 5-fluorouracil , 2009, Cellular and Molecular Life Sciences.
[11] K. Kang,et al. Elevation of cysteine consumption in tamoxifen-resistant MCF-7 cells. , 2013, Biochemical pharmacology.
[12] Jing Zhu,et al. Apparently low reproducibility of true differential expression discoveries in microarray studies , 2008, Bioinform..
[13] Koji Kadota,et al. A weighted average difference method for detecting differentially expressed genes from microarray data , 2008, Algorithms for Molecular Biology.
[14] Rongling Wu,et al. Differential Gene Expression in Tamoxifen-Resistant Breast Cancer Cells Revealed by a New Analytical Model of RNA-Seq Data , 2012, PloS one.
[15] Soumya Krishnamurthy,et al. Cellular Responses to Cisplatin-Induced DNA Damage , 2010, Journal of nucleic acids.
[16] Rainer Breitling,et al. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.
[17] Catalin C. Barbacioru,et al. The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies , 2008, BMC Bioinformatics.
[18] Jing Zhu,et al. Gaining confidence in biological interpretation of the microarray data: the functional consistence of the significant GO categories , 2008, Bioinform..
[19] J. Hayles,et al. Ubiquitin-proteasome genes as targets for modulation of cisplatin sensitivity in fission yeast , 2011, BMC Genomics.
[20] Xing Qiu,et al. The effects of normalization on the correlation structure of microarray data , 2005, BMC Bioinformatics.
[21] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[22] Andreas Rytz,et al. The limit fold change model: A practical approach for selecting differentially expressed genes from microarray data , 2002, BMC Bioinformatics.
[23] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[24] P. Hsieh,et al. The mismatch repair‐mediated cell cycle checkpoint response to fluorodeoxyuridine , 2008, Journal of cellular biochemistry.
[25] A. Naccarati,et al. Variations in mismatch repair genes and colorectal cancer risk and clinical outcome. , 2014, Mutagenesis.
[26] R. Kolodner,et al. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..
[28] Robert L. Sutherland,et al. Biological determinants of endocrine resistance in breast cancer , 2009, Nature Reviews Cancer.
[29] Johan Hansson,et al. Cisplatin Induces Endoplasmic Reticulum Stress and Nucleus-independent Apoptotic Signaling* , 2003, The Journal of Biological Chemistry.
[30] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[31] Jianjun Hu,et al. Density based pruning for identification of differentially expressed genes from microarray data , 2010, BMC Genomics.
[32] M. Dolan,et al. Molecular mechanisms of resistance and toxicity associated with platinating agents. , 2007, Cancer treatment reviews.
[33] Martin H. Schaefer,et al. Protein Conservation and Variation Suggest Mechanisms of Cell Type-Specific Modulation of Signaling Pathways , 2014, PLoS Comput. Biol..
[34] Lang He,et al. Revealing weak differential gene expressions and their reproducible functions associated with breast cancer metastasis , 2012, Comput. Biol. Chem..
[35] S. Howell,et al. DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistance , 2006, Molecular Cancer Therapeutics.
[36] C. Caldas,et al. Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer. , 2006, Cancer research.
[37] Shih-Chieh Lin,et al. Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer. , 2011, The American journal of pathology.
[38] Evelien Vaes,et al. Statistical analysis of differential gene expression relative to a fold change threshold on NanoString data of mouse odorant receptor genes , 2014, BMC Bioinformatics.
[39] Naveid A Ali,et al. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer , 2013, The FEBS journal.
[40] Maqc Consortium. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements , 2006, Nature Biotechnology.
[41] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[42] Sergio Contrino,et al. ArrayExpress—a public repository for microarray gene expression data at the EBI , 2004, Nucleic Acids Res..
[43] Tom C. T. Yin,et al. A Flexible Renewal Process Simulator for Neural Spike Trains , 1976, IEEE Transactions on Biomedical Engineering.
[44] M. Meyers,et al. DNA Mismatch Repair-dependent Response to Fluoropyrimidine-generated Damage* , 2005, Journal of Biological Chemistry.
[45] Hui Xiao,et al. Evaluating reproducibility of differential expression discoveries in microarray studies by considering correlated molecular changes , 2009, Bioinform..
[46] Jean-Pierre Gillet,et al. The clinical relevance of cancer cell lines. , 2013, Journal of the National Cancer Institute.
[47] B. Pfeifer,et al. Simultaneous production and partitioning of heterologous polyketide and isoprenoid natural products in an Escherichia coli two-phase bioprocess , 2011, Journal of Industrial Microbiology & Biotechnology.
[48] Yue Wu,et al. Chemotherapeutic sensitization by endoplasmic reticulum stress: Increasing the efficacy of taxane against prostate cancer , 2009, Cancer biology & therapy.
[49] B. Stordal,et al. Understanding cisplatin resistance using cellular models , 2007, IUBMB life.
[50] B. Henderson,et al. Targeting the DNA replication checkpoint by pharmacologic inhibition of Chk1 kinase: a strategy to sensitize APC mutant colon cancer cells to 5-fluorouracil chemotherapy , 2014, Oncotarget.
[51] M. Tan,et al. Targeting cellular metabolism to improve cancer therapeutics , 2013, Cell Death and Disease.
[52] Pierre Baldi,et al. A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes , 2001, Bioinform..
[53] A K Bahn,et al. Application of binomial distribution to medicine: comparison of one sample proportion to an expected proportion (for small samples). Evaluation of a new treatment. Evaluation of a risk factor. , 1969, Journal of the American Medical Women's Association.
[54] J. Claverie. Computational methods for the identification of differential and coordinated gene expression. , 1999, Human molecular genetics.
[55] Mylène Brunelle,et al. LRH-1 governs vital transcriptional programs in endocrine-sensitive and -resistant breast cancer cells. , 2014, Cancer research.
[56] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[57] R. Riggins,et al. Pathways to tamoxifen resistance. , 2007, Cancer letters.
[58] Peigen Xiao,et al. The First Insight into the Tissue Specific Taxus Transcriptome via Illumina Second Generation Sequencing , 2011, PloS one.
[59] P. Johnston,et al. 5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.
[60] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[61] Werner Van Belle,et al. Intensity Dependent Confidence Intervals on Microarray Measurements of Differentially Expressed Genes: A Case Study of the Effect of MK5, FKRP and TAF4 on the Transcriptome , 2007, Gene regulation and systems biology.